Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the effect of low dose of Tranexamic acid (1gm) and
Ethamsylate (1gm) after prophylactic oxytocin administration versus placebo with prophylactic
oxytocin given in the 2 minutes after child delivery in patient undergoing LSCS at high risk
for post partum hemorrhage